Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage Cell Therapeutics Inc

1.01
-0.0100-0.98%
Post-market: 1.020.0100+0.99%16:51 EDT
Volume:912.56K
Turnover:926.30K
Market Cap:230.64M
PE:-13.15
High:1.06
Open:1.04
Low:0.9930
Close:1.02
Loading ...
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 30, 2019

Major Issues Report

Current report, items 5.02 and 5.07
Jul 05, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jul 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 05, 2019

Major Issues Report

Current report, item 5.02
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 22, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
May 22, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 10, 2019

Major Issues Report

Current report, items 5.08 and 8.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 02, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 01, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]